Insulin Resistance as the Basis for the Comorbidity Development in Convalescents after COVID-19 and Patients With Chronic Obstructive Pulmonary Disease (COPD): Peculiarities of Manifestations and Changes under the Influence of Recovery Treatment
Tuberculosis, Lung Diseases, HIV Infection · 11.05.2026 · (2) · 32-40
DOI: 10.30978/tb2026-2-32 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberculosis, Lung Diseases, HIV Infection, online erschienen am 11.05.2026. Verfasst von O.I. Lemko und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Themen: COPD
Abstract (Originalsprache)
Consequences of Coronavirus infection have a significant impact on human health, which is associated with the development of post-COVID-19 syndrome. Objective — to study carbohydrate metabolism disorders in convalescents after COVID-19, including patients with chronic obstructive pulmonary disease (COPD), and their correction under the influence of recovery treatment based on haloaerosoltherapy (HAT). Materials and methods. A total of 87 convalescents after COVID-19 were examined, who had no history of pancreatic and bronchopulmonary diseases. Patients were examined within 1 month after the acute period (52 patients) and after 2—3 months (35 patients). 116 patients with COPD (GOLD II—III) were also examined, among whom 43 patients were convalescents after COVID-19. 12 practically healthy people formed a control group. Blood glucose, insulin, C-peptide levels were measured, and the HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) index was calculated. Investigations were conducted beginning of rehabilitation treatment and at the end of recovery treatment (after 21—22 days). The main component of treatment was HAT (rock salt aerosol media of certain concentration and dispersion). COPD patients received the necessary basic bronchodilator and anti-inflammatory therapy. Results and discussion. Carbohydrate metabolism disorders with the development of insulin resistance (IR) were detected in convalescents after COVID-19 before recovery treatment and these changes did not have a tendency for self-compensation within 2—3 months. At the same time, a relationship was found between the severity of IR and severity of the disease. When comparing the studied indices at convalescents after COVID-19 (group 1), patients with COPD (group 2) and patients with COPD who were convalescents after COVID-19 (group 3), it was found that carbohydrate metabolism disorders were most pronounced in patients of group 3. Under the influence of treatment, positive dynamics of the studied parameters were observed, but their normalisation was achieved only in convalescents after mild COVID-19. After the course of rehabilitation, the most pronounced carbohydrate metabolism disorders remained in patients of group 3. Conclusions. In convalescents after COVID-19, carbohydrate metabolism disorders with the development of IR were observed, the severity of which was associated with COVID-19 severity, and these changes did not have a tendency for self-compensation.Under the influence of HAT-based treatment, a decrease in IR manifestations was observed in all examined groups of patients. At the same time, normalisation the studied parameters was registered only in convalescents after a mild course of COVID-19. This fact determines the need for improvement of rehabilitation programmes in other groups of patients.
Zitieren
APA
Lemko, O., Vantiukh, N., & Reshetar, D. (2026). Insulin Resistance as the Basis for the Comorbidity Development in Convalescents after COVID-19 and Patients With Chronic Obstructive Pulmonary Disease (COPD): Peculiarities of Manifestations and Changes under the Influence of Recovery Treatment. Tuberculosis, Lung Diseases, HIV Infection, 32-40. https://doi.org/10.30978/tb2026-2-32
Vancouver
Lemko O, Vantiukh N, Reshetar D. Insulin Resistance as the Basis for the Comorbidity Development in Convalescents after COVID-19 and Patients With Chronic Obstructive Pulmonary Disease (COPD): Peculiarities of Manifestations and Changes under the Influence of Recovery Treatment. Tuberculosis, Lung Diseases, HIV Infection. 2026:32-40. doi:10.30978/tb2026-2-32
BibTeX
@article{Lemko2026,
author = {Lemko, O.I. and Vantiukh, N.V. and Reshetar, D.V.},
title = {Insulin Resistance as the Basis for the Comorbidity Development in Convalescents after COVID-19 and Patients With Chronic Obstructive Pulmonary Disease (COPD): Peculiarities of Manifestations and Changes under the Influence of Recovery Treatment},
journal = {Tuberculosis, Lung Diseases, HIV Infection},
year = {2026},
number = {2},
pages = {32--40},
doi = {10.30978/tb2026-2-32}
}
EUVIMED